Literature DB >> 10831929

Static and dynamic bone histomorphometry in children with osteogenesis imperfecta.

F Rauch1, R Travers, A M Parfitt, F H Glorieux.   

Abstract

Osteogenesis imperfecta (OI) is a genetic disorder characterized by increased bone fragility and low bone mass. Four clinical types are commonly distinguished. Schematically, type I is the mildest phenotype, type II is usually lethal, type III is the most severe form compatible with postnatal survival, and type IV is moderately severe. Although mutations affecting collagen type I are responsible for the disease in most patients, the mechanisms by which the genetic defects cause abnormal bone development have not been well characterized. Therefore, we evaluated quantitative static and dynamic histomorphometric parameters in tetracycline-labeled iliac bone biopsies from 70 children, aged 1.5 to 13.5 years, with OI types I (n = 32), III (n = 11), and IV (n = 27). Results were compared with those of 27 age-matched controls without metabolic bone disease. Biopsy core width, cortical width, and cancellous bone volume were clearly decreased in all OI types. Decreased cancellous bone volume was due to a 41%-57% reduction in trabecular number and a 15%-27% lower trabecular thickness. Regression analyses revealed that trabecular number did not vary with age in either controls or OI patients, indicating that no trabecular loss occurred. The annual increase in trabecular thickness was 5.8 microm in controls and 3.6 microm in type I OI, whereas no trabecular thickening was evident in type III and IV OI. Wall thickness, which reflects the amount of bone formed during a remodeling cycle, was decreased by 14% in a subgroup of 17 type I OI patients, but was not determined in the other OI types. The remodeling balance was less positive in type I OI than in controls, and probably close to zero in types III and IV. Surface-based parameters of bone remodeling were increased in all OI types, indicating increased recruitment of remodeling units. No defect in matrix mineralization was found. In conclusion, there was evidence of defects in all three mechanisms, which normally lead to an increase in bone mass during childhood; that is, modeling of external bone size and shape, production of secondary trabeculae by endochondral ossification, and thickening of secondary trabeculae by remodeling. Thus, OI might be regarded as a disease in which a single genetic defect in the osteoblast interferes with multiple mechanisms that normally ensure adaptation of the skeleton to the increasing mechanical needs during growth.

Entities:  

Mesh:

Year:  2000        PMID: 10831929     DOI: 10.1016/s8756-3282(00)00269-6

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  73 in total

1.  Characterization of eight different tetracyclines: advances in fluorescence bone labeling.

Authors:  Christoph Pautke; Stephan Vogt; Kilian Kreutzer; Cornelia Haczek; Gabriele Wexel; Andreas Kolk; Andreas B Imhoff; Horst Zitzelsberger; Stefan Milz; Thomas Tischer
Journal:  J Anat       Date:  2010-04-26       Impact factor: 2.610

Review 2.  Treatment of children with osteogenesis imperfecta.

Authors:  Frank Rauch; Francis H Glorieux
Journal:  Curr Osteoporos Rep       Date:  2006-12       Impact factor: 5.096

Review 3.  Unexplained fractures in infancy: looking for fragile bones.

Authors:  Nick Bishop; Alan Sprigg; Ann Dalton
Journal:  Arch Dis Child       Date:  2007-03       Impact factor: 3.791

4.  Skeletal cell YAP and TAZ combinatorially promote bone development.

Authors:  Christopher D Kegelman; Devon E Mason; James H Dawahare; Daniel J Horan; Genevieve D Vigil; Scott S Howard; Alexander G Robling; Teresita M Bellido; Joel D Boerckel
Journal:  FASEB J       Date:  2018-01-10       Impact factor: 5.191

5.  Immature osteoblast lineage cells increase osteoclastogenesis in osteogenesis imperfecta murine.

Authors:  Haitao Li; Xi Jiang; John Delaney; Tiziana Franceschetti; Ines Bilic-Curcic; Judy Kalinovsky; Joseph A Lorenzo; Danka Grcevic; David W Rowe; Ivo Kalajzic
Journal:  Am J Pathol       Date:  2010-03-26       Impact factor: 4.307

Review 6.  Osteogenesis imperfecta and therapeutics.

Authors:  Roy Morello
Journal:  Matrix Biol       Date:  2018-03-11       Impact factor: 11.583

Review 7.  Hematopoietic stem cells are pluripotent and not just "hematopoietic".

Authors:  Makio Ogawa; Amanda C LaRue; Meenal Mehrotra
Journal:  Blood Cells Mol Dis       Date:  2013-02-27       Impact factor: 3.039

8.  Children with special physical health care needs: restraint use and injury risk in motor vehicle crashes.

Authors:  Patty Huang; Michael J Kallan; Joseph O'Neil; Marilyn J Bull; Nathan J Blum; Dennis R Durbin
Journal:  Matern Child Health J       Date:  2011-10

9.  Gender-dependence of bone structure and properties in adult osteogenesis imperfecta murine model.

Authors:  Xiaomei Yao; Stephanie M Carleton; Arin D Kettle; Jennifer Melander; Charlotte L Phillips; Yong Wang
Journal:  Ann Biomed Eng       Date:  2013-03-28       Impact factor: 3.934

Review 10.  Efficacy of oral etidronate for skeletal diseases in Japan.

Authors:  Jun Iwamoto; Tsuyoshi Takeda; Yoshihiro Sato
Journal:  Yonsei Med J       Date:  2005-06-30       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.